BRIDGEBIO PHARMA INC (BBIO) Earnings History & Surprises
NASDAQ:BBIO • US10806X1028
67.98 USD
-3.41 (-4.78%)
At close: Mar 12, 2026
67.98 USD
0 (0%)
After Hours: 3/12/2026, 8:24:25 PM
Past quarterly earnings results for BRIDGEBIO PHARMA INC (BBIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 27, 2026
PeriodQ1 / 2026
EPS Estimate-$0.67
Revenue Estimate181.28M
Last Reported
Release DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported-$1.00
EPS Surprise -32.11%
Revenue Surprise 2.94%
Beat Rate
56%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.00 | -0.76 | -32.11% | 28.57% | 154.178M | 149.78M | 2.94% | 2,521.18% |
| Q3 2025 | -0.95 | -0.91 | -4.81% | 13.64% | 120.7M | 108.51M | 11.23% | 4,318.01% |
| Q2 2025 | -0.95 | -0.86 | -10.44% | -143.59% | 110.565M | 93.238M | 18.58% | 4,999.86% |
| Q1 2025 | -0.88 | -0.94 | 6.56% | -340.00% | 116.633M | 63.179M | 84.61% | -44.76% |
| Q4 2024 | -1.40 | -1.15 | -21.38% | -45.83% | 5.882M | 3.549M | 65.74% | 237.08% |
| Q3 2024 | -1.10 | -1.00 | -10.20% | -1.85% | 2.732M | 3.837M | -28.80% | -33.22% |
| Q2 2024 | -0.39 | -1.09 | 64.07% | 60.20% | 2.168M | 3.641M | -40.46% | 32.11% |
| Q1 2024 | -0.20 | -0.78 | 74.34% | 78.26% | 211.12M | 14.314M | 1,374.92% | 11,461.88% |
| Q4 2023 | -0.96 | -0.93 | -3.37% | -4.35% | 1.745M | 6.353M | -72.53% | -6.68% |
| Q3 2023 | -1.08 | -0.83 | -29.83% | -16.13% | 4.091M | 4.118M | -0.66% | 1,103.24% |
| Q2 2023 | -0.98 | -0.85 | -15.29% | -1,300.00% | 1.641M | 3.053M | -46.25% | -97.77% |
| Q1 2023 | -0.92 | -0.85 | -8.52% | 22.69% | 1.826M | 3.443M | -46.96% | 8.05% |
| Q4 2022 | -0.92 | -0.87 | -5.84% | 8.91% | 1.87M | 4.615M | -59.48% | -85.49% |
| Q3 2022 | -0.93 | -1.01 | 8.30% | 12.26% | 340K | 8.063M | -95.78% | -85.47% |
| Q2 2022 | -0.07 | -0.64 | 89.13% | 89.39% | 73.75M | 16.389M | 350.00% | 36.52% |
| Q1 2022 | -1.19 | -1.13 | -5.11% | -0.85% | 1.69M | 4.789M | -64.71% | 267.39% |
| Q4 2021 | -1.01 | -0.89 | -14.11% | - | 12.89M | 22.009M | -41.43% | 10,641.67% |
| Q3 2021 | -1.06 | -0.92 | -15.33% | -8.16% | 2.34M | 17.706M | -86.78% | -71.22% |
| Q2 2021 | -0.66 | -0.96 | 31.27% | 35.92% | 54.02M | 35.536M | 52.01% | - |
| Q1 2021 | -1.18 | -0.75 | -56.60% | -51.28% | 460K | 31.091M | -98.52% | - |
| Q4 2020 | -1.01 | -0.87 | -16.65% | - | 120K | 17.269M | -99.31% | - |
| Q3 2020 | -0.98 | -0.94 | -4.43% | - | 8.13M | 8.772M | -7.32% | - |
| Q2 2020 | -1.03 | -0.79 | -30.80% | - | - | - | ||
| Q1 2020 | -0.78 | -0.68 | -13.89% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-10.20%
Max EPS beat (4)
6.56%
Min EPS beat (4)
-32.11%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
29.34%
Max Revenue beat (4)
84.61%
Min Revenue beat (4)
2.94%
Analysis
In the last 4 quarters, BBIO has beaten EPS estimates in 1 out of 4 releases
BBIO has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, BBIO reported -10.2% below the EPS estimates on average.
In the last 4 quarters, BBIO has beaten the revenue estimates by 29.3% on average.
BRIDGEBIO PHARMA INC / BBIO Earnings FAQ
What is the most recent earnings date for BBIO stock?
BRIDGEBIO PHARMA INC (BBIO) last reported earnings on 2/24/2026.
Did BBIO stock beat earnings estimates in the most recent quarter?
BRIDGEBIO PHARMA INC (BBIO) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often BRIDGEBIO PHARMA INC beats earnings estimates?
In the last 4 quarters, BRIDGEBIO PHARMA INC (BBIO) has beaten EPS estimates in 1 out of 4 releases.